Arimoto, K., Hishiki, T., Kiyonari, H., Abe, T., Cheng, C., Yan, M., Fan, J. B., Futakuchi, M., Tsuda, H., Murakami, Y., Suzuki, H., Zhang, D. E., & Shimotohno, K. (2015). Murine Herc6 plays a critical role in protein ISGylation in vivo and has an ISGylation-independent function in seminal vesicles. Journal of Interferon and Cytokine Research, 35(5), 351–358. https://doi.org/10.1089/jir.2014.0113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayub, S. G., & Kaul, D. (2017). miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer. Andrology, 5(4), 790–797.

Article  CAS  PubMed  Google Scholar 

Bhargava, S., Patil, V., Mahalingam, K., & Somasundaram, K. (2017). Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma. Oncotarget, 8(10), 16650–16668. https://doi.org/10.18632/oncotarget.14287

Article  PubMed  Google Scholar 

Burks, J., Fleury, A., Livingston, S., & Smith, J. P. (2019). ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression. Cancer Immunology, Immunotherapy, 68(12), 2029–2039. https://doi.org/10.1007/s00262-019-02422-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burks, J., Reed, R. E., & Desai, S. D. (2014). ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene, 33(6), 794–803.

Article  CAS  PubMed  Google Scholar 

Cao, S., Li, N., & Liao, X. (2021). miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer. Journal of Ovarian Research, 14(1), 23. https://doi.org/10.1186/s13048-020-00760-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai, Y., Yu, T., Yu, C., Lu, T., Zhou, Lu., Cheng, C., & Ni, H. (2022). ISG15 enhances glioma cell stemness by promoting Oct4 protein stability. Environmental Toxicology, 37(9), 2133–2142.

Article  CAS  PubMed  Google Scholar 

Fan, J.-B., Miyauchi-Ishida, S., Arimoto, K.-I., Liu, D., Yan, M., Liu, C.-W., Győrffy, B., & Zhang, D.-E. (2015). Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation. Proceedings of the National Academy of Sciences., 112(46), 14313–14318.

Article  CAS  Google Scholar 

Hermann, M. R., Jakobson, M., Colo, G. P., Rognoni, E., Jakobson, M., Kupatt, C., Posern, G., & Fassler, R. (2016). Integrins synergise to induce expression of the MRTF-A-SRF target gene ISG15 for promoting cancer cell invasion. Journal of Cell Science, 129(7), 1391–1403. https://doi.org/10.1242/jcs.177592

Article  CAS  PubMed  Google Scholar 

Huibregtse, J. M., Scheffner, M., Beaudenon, S., & Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proceedings of the National Academy of Sciences, 92(11), 5249. https://doi.org/10.1073/pnas.92.11.5249-b

Article  CAS  Google Scholar 

Jin, J., Meng, X., Huo, Y., & Deng, H. (2021). Induced TRIM21 ISGylation by IFN-beta enhances p62 ubiquitination to prevent its autophagosome targeting. Cell Death & Disease, 12(7), 697. https://doi.org/10.1038/s41419-021-03989-x

Article  CAS  Google Scholar 

Kosti, A., de Araujo, P. R., Li, W. Q., Guardia, G. D. A., Chiou, J., Yi, C., Ray, D., Meliso, F., Li, Y. M., Delambre, T., Qiao, M., Burns, S. S., Lorbeer, F. K., Georgi, F., Flosbach, M., Klinnert, S., Jenseit, A., Lei, X., Sandoval, C. R., et al. (2020). The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation. Genome Biology, 21(1), 195. https://doi.org/10.1186/s13059-020-02115-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, C., Wang, J., Zhang, H., Zhu, M., Chen, F., Hu, Y., Liu, H., & Zhu, H. (2014). Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget, 5(18), 8429–8441. https://doi.org/10.18632/oncotarget.2316

Article  PubMed  PubMed Central  Google Scholar 

Liu, C., Li, L., Hou, G., Lu, Y., Gao, M., & Zhang, L. (2022). HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. Life Sciences, 303, 120692. https://doi.org/10.1016/j.lfs.2022.120692

Article  CAS  PubMed  Google Scholar 

Lo, P.-K., Yao, Y., Lee, J. S., Zhang, Y., Huang, W., Kane, M. A., & Zhou, Q. (2018). LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer. eLife, 7, e31334.

Article  PubMed  PubMed Central  Google Scholar 

Mirzalieva, O., Juncker, M., Schwartzenburg, J., & Desai, S. (2022a). ISG15 and ISGylation in human diseases. Cells. https://doi.org/10.3390/cells11030538

Article  PubMed  PubMed Central  Google Scholar 

Mirzalieva, O., Juncker, M., Schwartzenburg, J., & Desai, S. (2022b). ISG15 and ISGylation in human diseases. Cells, 11(3), 538.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mustachio, L. M., Kawakami, M., Lu, Y., Rodriguez-Canales, J., Mino, B., Behrens, C., Wistuba, I., Bota-Rabassedas, N., Yu, J., & Lee, J. J. (2017). The ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget, 8(1), 3.

Article  PubMed  Google Scholar 

Mustachio, L. M., Lu, Y., Kawakami, M., Roszik, J., Freemantle, S. J., Liu, Xi., & Dmitrovsky, E. (2018). Evidence for the ISG15-specific deubiquitinase USP18 as an antineoplastic target. Cancer Research, 78(3), 587–592.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, S.-Y., Yoon, S., Kim, H., & Kim, K. K. (2016). 90K glycoprotein promotes degradation of mutant β-catenin lacking the ISGylation or phosphorylation sites in the N-terminus. Neoplasia, 18(10), 618–625.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin, Y., Meng, X., Wang, M., Liang, W., Xu, R., Chen, J., Song, H., Fu, Y., Li, J., Gao, C., Jia, M., Zhao, C., & Zhao, W. (2023). Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI161935

Article  PubMed  PubMed Central  Google Scholar 

Qu, T., Zhang, W., Yan, C., Ren, D., Wang, Y., Guo, Y., Guo, Q., Wang, J., Liu, L., Han, L., Li, L., Huang, Q., Cao, L., Ye, Z., Zhang, B., Zhao, Q., & Cao, W. (2023). ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma. Journal of Translational Medicine, 21(1), 341. https://doi.org/10.1186/s12967-023-04135-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanchez-Tena, S., Cubillos-Rojas, M., Schneider, T., & Rosa, J. L. (2016). Functional and pathological relevance of HERC family proteins: A decade later. Cellular and Molecular Life Sciences, 73(10), 1955–1968. https://doi.org/10.1007/s00018-016-2139-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan, B., Qu, S., Lv, S., Fan, D., & Wang, S. (2022). YY1-induced long non-coding RNA small nucleolar RNA host gene 8 promotes the tumorigenesis of melanoma via the microRNA-656-3p/SERPINE1 mRNA binding protein 1 axis. Bioengineered, 13(3), 4832–4843. https://doi.org/10.1080/21655979.2022.2034586

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shetty, S., Hofstetter, J., Battaglioni, S., Ritz, D., & Hall, M. N. (2023). TORC1 phosphorylates and inhibits the ribosome preservation factor Stm1 to activate dormant ribosomes. The EMBO Journal, 42(5), e112344. https://doi.org/10.15252/embj.2022112344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020). Management of glioblastoma: State of the art and future directions. J CA: A Cancer Journal for Clinicians, 70(4), 299–312.

PubMed  Google Scholar 

Tecalco-Cruz, A. C., Velasco-Loyden, G., Robles-Villarruel, L., Cortes-González, C. C., Zepeda-Cervantes, J., Pineda, B., & de Sánchez, V. C. (2022). Interferon-stimulated gene 15 and ISGylation are upregulated in glioblastoma. Biochemical and Biophysical Research Communications, 621, 144–150.

Article  CAS  PubMed